- The impact of prior SARS-CoV-2 infection and vaccination on Omicron infection News-Medical.Net
- Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside | Signal Transduction and Targeted Therapy Nature.com
- 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection The Lancet
- New research identifies natural compounds with pan-SARS-CoV-2 inhibitory activity News-Medical.Net
- Innate immune evasion strategies of SARS-CoV-2 Nature.com
- View Full coverage on Google News
from Health - Latest - Google News
0 comments:
Post a Comment